Related Content

Getting the Word Out

As the specialty pharmacy market grows, so too should the effort to communicate potential interactions.

DEA Form 106 and Loss of Controlled Substances

A pharmacy must report the theft or significant loss of controlled substances to the DEA within one business day.

The Economic Burden of Mental Health Care

In 2003, 6.2% ($100 billion) of the $1,614 billion spent on healthcare was for mental health care.

An Rx for Satisfaction & Success

Pharmacies continue to earn the highest survey scores for patient satisfaction.

State May Regulate Dispensing of Emergency Contraception

This ruling is the latest in a series of judgments on whether religious believers can opt out of providing services.

No Serious CV Event Increase for Breast Cancer Patients on Aromatase Inhibitors 5/4/2016

Large Review Underscores Aspirin Benefit in Reducing Colorectal Cancer 3/23/2016

Breaking Down Glioma: A Pharmacist’s Overview 2/17/2016

Gliomas are central nervous system tumors that arise from glial cells in the brain or spine.

Is Earlier Colorectal Cancer Screening Beneficial? 2/17/2016

Breast Cancer Recurrence Not Increased When Antidepressants Taken With Tamoxifen 1/20/2016

Outcomes Better for Ovarian Cancer Patients With Past OC Use 12/18/2015

FDA Approves Three New Treatments for Multiple Myeloma 12/14/2015

Form of Vitamin B Reduces Nonmelanoma Skin Cancer Risk 11/13/2015

ADT Lowers Survival in Prostate Cancer Patients With Certain Comorbidities 10/7/2015

Stage-Based Treatment for Cervical Cancer 9/15/2015

Routine screening helps identify the disease in its early stages.

Younger Patients Decline Tamoxifen Because of Fertility Concerns 9/9/2015

End-Stage Chemotherapy Often Not Beneficial 8/18/2015


Melanoma Rates Rise Steeply in Children and Young Adults 6/23/2015

Nanotechnology Identifies Brain Tumor Types in Animal Studies 6/22/2015

Boosting Healthy Cell Production During Chemotherapy 1/21/2015

Management of Chemotherapy-Induced Peripheral Neuropathy 1/21/2015

Up to 40% of patients undergoing chemotherapy with multiple agents experience nerve damage.

Preventive Effect of Tamoxifen Is Long-Lasting 1/21/2015

Missing Link Between Vitamin D and Prostate Cancer 11/17/2014

Selenium May Be Effective Against Breast Cancer 11/17/2014

Contribution to Breast Cancer Prevention for Women: A Challenge for Pharmacists 9/17/2014

New guidelines recommend chemoprevention (tamoxifen or raloxifene) for high-risk patients.

Breakthrough Therapy Approved for Leukemia and Lymphoma 8/20/2014

Bacteria-Causing Gum Disease Invites Oral Cancer Growth 3/19/2014

Combining Cervical Cancer Drugs, Chemo to Extend Life 3/19/2014

Nanoparticles Target Cancer-Fighting Immune Cells 3/19/2014

Exhaled Breath May Signal Early Lung Cancer 2/19/2014

Study: Mammography Benefits Younger Women 2/19/2014

The Cardiotoxicity of Cancer-Related Drug Therapies 2/19/2014

Cardiotoxicity, in which the heart muscle is damaged and cannot efficiently pump blood to oxygenate the body’s vital organs, is one of the most prominent morbidities in cancer patients surviving 5 to 10 years post therapy.

Resveratrol Could Help Treat a Variety of Cancer Types 11/15/2013

Omega-3s May Raise Risk of Prostate Cancer 8/20/2013

Gene Mutation’s Link to Aspirin Efficacy in Colorectal Cancer 7/17/2013

Protein and Prostate Cancer Progression 7/17/2013

At-Home Test for Prostate Cancer in Development 6/21/2013

Selumetinib Promising Against Ovarian Cancer 3/20/2013

Cancer Cells Exploit Immune Response to Survive 1/23/2013

Iclusig Approved to Treat Two Forms of Leukemia 1/23/2013

Overview of Pancreatic Cancer 12/19/2012

Pancreatic cancer is a devastating and lethal disease affecting one in 68 Americans.

Daily Multivitamins Reduce Risk of Cancer in Men 11/20/2012

Routine PSA Tests Not Recommended 6/20/2012

Paternal Genes Linked to Early Breast Cancer 1/20/2012

Possible Leukemia Cure Found in Fish Oil 1/20/2012

Avastin’s Breast Cancer Indication Revoked 12/20/2011

Therapeutic Agents in Osteosarcoma 10/19/2011

Novel agents are being investigated to achieve a better therapeutic outcome and a reduction in adverse events. 

HercepTest for the Detection of HER2 Protein Overexpression in Breast and Gastric Cancers 9/20/2011

This assay helps determine whether trastuzumab treatment may be considered. 

Some Herbal Supplements May Adversely Affect Chemotherapy 9/20/2011

Avastin’s Breast Cancer Indication May Be Pulled 8/19/2011

ACS Reports on Cancer Mortality 7/20/2011

Bladder Cancer: A Review 6/20/2011

In 2010, the urinary bladder was the fourth most common site of new cancer cases in the United States, with an estimated 70,530 new cases and 14,680 deaths.

Coffee May Lower Risk of Prostate Cancer 6/20/2011

Compound Prevents Prostate Cancer Cell Growth 1/20/2011

New Late-Stage Breast Cancer Treatment Approved 12/17/2010

Capsaicin Linked to Skin Cancer 10/20/2010

View Full Article

Hodgkin’s Lymphoma 10/20/2010

Lymphoma is a form of cancer that affects the lymphatic system, a part of the body’s immune system that helps fight infection.

Increasing Selenium May Reduce Bladder Cancer Risk 10/20/2010

Low-Dose Aspirin Protects Against Bowel Cancer 10/20/2010

Metastatic Melanoma Treatment Fast Tracked 10/20/2010

Therapy Effective Against Aggressive Thyroid Cancer 10/20/2010

TOP2A FISH pharmDx Kit: A Tool for Assessing Breast Cancer Prognosis 9/20/2010

This kit is a tool for use in assessing the clinical course of breast cancer and response to therapy in certain patients with the disease.

Clinical Evidence That Anticancer Drug Triggers Viral Infection 5/20/2010

Coffee Could Protect Against Diabetes, Prostate Cancer 1/20/2010

Colorectal Cancer Screening 12/17/2009

Routine examinations, beginning at age 50, are key to preventing this disease and saving lives.

View Full Article

Newly Approved mTOR Inhibitors for the Treatment of Metastatic Renal Cell Carcinoma 11/19/2009

Temsirolimus and everolimus are now indicated as therapy for this type of cancer.

Prostate Cancer May Cause Neglect of Other Diseases 2/20/2009

Breast Tumor Characteristics Predict Contralateral Disease 2/20/2009

Targeted Therapy with Tyrosine Kinase Inhibitors 10/17/2008

ABSTRACT: Tyrosine kinases are a family of proteins that contribute to the development of cancer.

Thalidomide: New Cancer Uses for an Old Drug 7/18/2008

ABSTRACT: Thalidomide, a drug once thought to have no clinical benefit due to its significant toxicity, has now become a potential agent for the treatment of hematologic malignancies and some solid tumors.

Drug Combination Slows Prostate Cancer Growth 7/18/2008

Attendees at a meeting of the American Association for Cancer Research learned that while the results of a study conducted at Rutgers University in New Brunswick, NJ, showed that atorva­ statin (Lipitor) and celecoxib (Celebrex) individually slowed tumor progression from androgen-dependent to androgen-independent status, the two drugs combined had additive growth-inhibiting activity compared with either drug alone.

Anticoagulation Management in Patients with Cancer 7/18/2008

ABSTRACT: Cancer, chemotherapy, and surgery are conditions that increase the risk of the development of venous thromboembolism (VTE), a common and potentially life-threatening condition.

Can NSAIDs Play a Role in Preventing Cancer? 5/20/2008

Researchers at the National Sun Yat-Sen University and Kaohsiung Medical University in Taiwan say they've uncovered a mechanism by which nonsteroidal anti-inflammatory drugs (NSAIDs) attenuate tumor invasion and metastasis, leading them to think that NSAIDs may be a novel class of effective chemopreventive drugs.

NSAIDs May Play Role in Reducing Breast Cancer 4/18/2008

Researchers at London's Guy's Hospital said that aspirin and similar non-steroidal anti-inflammatory drugs (NSAIDs) could reduce breast cancer by up to 20%.

The Third-Generation Aromatase Inhibitors 4/18/2008

Adverse effects of AIs include cardiovascular dysfunction such as hypertension, vasodilation, edema, and chest pain.

Goals of Therapy for Multiple Myeloma 4/18/2008

ABSTRACT: Multiple myeloma accounts for approximately 1% of new cancer diagnoses in the United States each year.

Skin Cancer 4/18/2008

ABSTRACT: Skin, the largest organ in the human body, has several functions, including protection from mechanical, thermal, and environmental impact.

Patterns in Sun-Protection Behaviors 4/18/2008

Between 1975 and 2004 the number of new cases of melanoma rose, and it is estimated that 60,000 new cases occurred in 2007.

Iris BioTechnologies Introduces Nano-Biochip for Breast Cancer 3/20/2008

Iris BioTechnologies focuses on diagnostic therapy for individual patients based on their genomic profile.

A Review of Tumor Lysis Syndrome  3/10/2008

ABSTRACT: Tumor lysis syndrome (TLS), an oncologic emergency, results when cancer cells are rapidly lysed after chemotherapy or other treatments.

Osteosarcoma and Dose-Intensive Chemotherapy 3/10/2008

ABSTRACT: The frequency of bone cancer is very rare, with only 400 to 700 new cases diagnosed annually.

Cancer Continues Its Deadly Track 2/20/2008

According to a report from the American Cancer Society, 12 million new cases of malignancy were diagnosed worldwide in 2007; this translates to 7.6 million people dying from the disease.

Fewer Children Are Dying from Cancer 2/20/2008

Despite a 0.6% increase in pediatric malignancies, The Centers for Disease Control and Prevention said that fewer children are dying from cancers. In a report by Loria Pollack, MD, and colleagues that was published in Mortality and Morbidity Weekly Report, the researchers stated that the lower pediatric mortality rate of cancer in the U.S. "likely reflects advances in cancer treatment in this population."

Focus on Phytoestrogens 12/20/2007

Phytoestrogens are trace biochemicals produced by plants that act like estrogens in animal cells and bodies.

Enhancing Patient Adherence to Improve Outcomes With Oral Chemotherapy 10/18/2007

The post-test exam and post-activity evaluation form are available at www.

Cancer News 10/18/2007

Key Myeloma Mechanism Discovered In a discovery that might lead to a greater understanding of how multiple myeloma starts and how to best treat the disease, researchers from the National Cancer Institute (NCI)  have identified changes to molecules in cancer cells that activate the NF-kappaB signaling pathway, which has an important role in cancer cell growth and survival.

Hormonal Therapies in Breast and Prostate Cancers 10/18/2007

ABSTRACT: In the United States, breast cancer and prostate cancer are the most common types of cancer diagnosed in women and men, respectively.

Many Women on Oral Contraceptives Not at Overall Risk for Cancer 10/18/2007

According to a study done at the University of Aberdeen, Scotland, there is good news for women who take oral contraceptives for eight or fewer years.

Targeted Therapies for NSCLC 10/18/2007

ABSTRACT: Non–small cell lung cancer (NSCLC) continues to be the leading cause of cancer death in the United States, and treatment for patients with advanced NSCLC remains an important, clinically complex challenge.

Cancer/AIDS News 7/13/2007

Childhood Cancer Survivors Have Higher Health Risks as Adults While more effective treatments for childhood cancers have dramatically improved survival rates, children who had been treated for cancer could to be at a higher risk of health problems as adults.

Management of Chronic Myelogenous Leukemia 7/13/2007

ABSTRACT: Chronic myelogenous leukemia (CML) is a hematologic malignancy associated with chromosomal abnormalities, including the Philadelphia chromosome (Ph).

Prostate Cancer: Focus on Therapeutic Vaccines 7/13/2007

ABSTRACT: Therapeutic cancer vaccines differ from traditional vaccines in that they are only given to patients who already have cancer, with the goal of decreasing the spread of the disease and prolonging survival.

Therapeutic Approaches to Coagulopathy in Cancer Patients 7/13/2007

ABSTRACT: In the United States, it is estimated that the frequency of venous thromboembolism (VTE) among cancer patients is approximately 1 in 200.

Clinical News Digest 7/13/2007

ED Drugs May Have Other Benefits Studies recently presented at the American Urological Association meeting point to the fact that type 5 phosphodiesterase (PDE5) inhibitors used in the treatment of erectile dysfunction (ED) may be effective against benign prostatic hyperplasia (BPH) and lower urinary tract symptoms.

Clinical News Digest 6/19/2007

Regular Aspirin Use Reduces Risk of Colon Cancer

Chemotherapy-Induced Anemia in Patients with Cancer 4/17/2007

Erythropoiesis, or the production of erythrocytes (i.

Topical of Imiquimod 5% Cream in Organ Transplant Recipients 4/17/2007

Skin cancer occurrence in organ transplant recipients (OTRs) is a rising phenomenon.

Chemotherapy for Prostate Cancer 4/17/2007

Prostate cancer is the most common solid tumor affecting men in the United States.

A New Era of Anticoagulation  3/21/2007

Thromboembolism is one of the leading causes of morbidity and mortality in the United States.

Future Technology for Warfarin Dosing 3/21/2007

Blood clotting is a very complicated process.

Cancer/AIDS News 3/21/2007

Circumcision Reduces HIV Transmission Two studies in the Lancet bring the number of studies establishing a strong link between circumcision and a reduction in the risk of HIV transmission to three.

Clinical News Digest 1/23/2007

Body Fluid Displacement Can Lead to Sleep Apnea

Cancer News 1/23/2007

Breast Cancer Patients May Benefit from Second Opinion

A Review of the 2006 ASCO Antiemetic Guidelines Update 1/23/2007

ABSTRACT: Emesis as an adverse event of antineoplastic therapy can be troublesome for many oncology patients.

A Review of Renal Cell Carcinoma 1/23/2007

In the United States, kidney cancer (renal cell carcinoma) is estimated to be the seventh most common cancerous condition diagnosed in men and the 13th most common in women, accounting for 2.7% of all malignant conditions.